| Literature DB >> 17712421 |
Ken Dawson-Scully1, Gary A B Armstrong, Clement Kent, R Meldrum Robertson, Marla B Sokolowski.
Abstract
Although it is acknowledged that genetic variation contributes to individual differences in thermotolerance, the specific genes and pathways involved and how they are modulated by the environment remain poorly understood. We link natural variation in the thermotolerance of neural function and behavior in Drosophila melanogaster to the foraging gene (for, which encodes a cGMP-dependent protein kinase (PKG)) as well as to its downstream target, protein phosphatase 2A (PP2A). Genetic and pharmacological manipulations revealed that reduced PKG (or PP2A) activity caused increased thermotolerance of synaptic transmission at the larval neuromuscular junction. Like synaptic transmission, feeding movements were preserved at higher temperatures in larvae with lower PKG levels. In a comparative assay, pharmacological manipulations altering thermotolerance in a central circuit of Locusta migratoria demonstrated conservation of this neuroprotective pathway. In this circuit, either the inhibition of PKG or PP2A induced robust thermotolerance of neural function. We suggest that PKG and therefore the polymorphism associated with the allelic variation in for may provide populations with natural variation in heat stress tolerance. for's function in behavior is conserved across most organisms, including ants, bees, nematodes, and mammals. PKG's role in thermotolerance may also apply to these and other species. Natural variation in thermotolerance arising from genes involved in the PKG pathway could impact the evolution of thermotolerance in natural populations.Entities:
Mesh:
Substances:
Year: 2007 PMID: 17712421 PMCID: PMC1945089 DOI: 10.1371/journal.pone.0000773
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Figure 1Hyperthermic failure of both behavior and NMJ synaptic transmission in 3rd instar for, for and for larvae.
(A) Temperature at behavioral failure of mouth hook movement significantly differed between larvae with different for genotypes, for failed at 37.2°C±0.3 (N = 30), for failed at 39.2°C±10.4 (N = 30) and for failed at 41.2°C±0.3 (N = 30). Significant differences were found across groups (Kruskal-Wallis on ranks, H(2,90) = 37.617, p<0.001) where letters (A, B, C) denote significant differences using a post-hoc test (Tukey, p<0.05). (B) Hyperthermic failure of evoked excitatory junction potential (EJP) failure (see inset) at the NMJ N>5 for all genotype and treatment combinations. Decreased thermotolerance of evoked synaptic transmission correlated with genotype (for>for>for for thermotolerance), where significant differences were found across treatment groups (Two Way ANOVA, F(5,118) = 175.20, p<0.001). The involvement of PKG activity in thermotolerance was confirmed using pharmacological agents to activate PKG (40 µM 8-Bromo cGMP), inhibit PKG (1 µM KT5823) or inhibit a PKG phosphorylation target PP2A (1 µM Cantharidin). A combination of 8-Bromo cGMP and Cantharidin was also used, demonstrating that Cantharidin likely acts downstream of PKG activation. The three genotypes did not differ after being treated with a prior heat shock of 36°C for 1 hour and a 30 minute recovery. Letters in histogram bars represent statistical groupings using a post-hoc test, whereby bars with different letters are significantly different (Tukey, p<0.05). Error bars represent SEM.
Figure 2Hyperthermic failure of locust ventilatory motor pattern generation.
(A) Sample traces of the ventilatory rhythm recorded from an abdominal expiratory muscle in a control locust. Note the ventilatory arrhythmias prior to failure. At failure, temperature was allowed to return to room temperature and time to recovery was recorded. Note that the ventilatory motor pattern after recovery is at a lower frequency just prior to failure because the temperature is lower. (B) Three separate experiments were performed to examine the pharmacological effects of i) PKG and PKA inhibitors ii) PP2A inhibitor and iii) PKG activator and PKG activator coupled with the PP2A inhibitor. (B i) Reduction in PKG activity (1 µM KT5823) increased the thermotolerance of neural function as strongly as a prior heat shock treatment during hyperthermia, whereas PKA inhibition (1 µM Rp-cAMP) had no effect. Significant treatment effects were found (ANOVA F(4,31) = 18.71, p<0.001; N>4 for all treatments) where letters (A, B, C) denote significant differences using a post-hoc test (Tukey, p<0.05). (B ii) Reduction of PP2A activity (1 µM Cantharidin) also increased the thermotolerance of neural function during hyperthermia where significant treatment effects were found (ANOVA F(3,31) = 4.60, p<0.001; N>6 for all treatments). (B iii) Activation of PKG using 40 µM 8-Bromo cGMP did not increase the thermotolerance of the circuit, but abolished the protective effects of heat shock preconditioning. Moreover, the PP2A inhibitor Cantharidin counteracted the effect of 8-Bromo cGMP in HS animals thereby inducing maximal thermotolerance. Significant treatment effects were found (ANOVA F(4,41) = 9.60, p<0.001; N>6 for all treatments). (C) Recovery time of the motor pattern upon return to room temperature showed corresponding differences in the same treatment groups (short recovery times associated with high failure temperatures in B). Here too significant differences were found across treatments: i) ANOVA F(4,31) = 7.62, p<0.001, N>4; ii) ANOVA F(3,32) = 19.65, p<0.001, N>6; iii) ANOVA F(4,41) = 4.78, p<0.001, N>6, Letters in histogram bars represent statistical groupings whereby bars with different letters are significantly different using a post-hoc test (Tukey, p<0.05). Error bars represent SEM.